DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.
Maria S LindgrenErik HansenNessn H AzawiAnna M NielsenLars DyrskjøtJørgen Bjerggaard JensenPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Short-term intensive chemoresection is an effective treatment strategy for recurrent NMIBC that leads to a reduced number of required procedures without compromising long-term oncological safety.